Transaminase for degrading and hydrolyzing fumonisins HFB1 and application of transaminase
By developing a novel transaminase, FumSPTA, the problem of scarce HFB1 degrading enzyme resources has been solved, enabling efficient and stable conversion of HFB1 into low-toxic products suitable for agriculture, feed, and food industries, thus reducing the health risks of fumonisins.
Patent Information
- Application Number
- CN202610676797.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-05-18
- Publication Date
- 2026-07-24
AI Technical Summary
The existing HFB1 degrading enzyme resources are scarce and have insufficient catalytic activity, making it difficult to achieve efficient and stable detoxification, and posing safety hazards and the risk of nutrient loss.
A novel transaminase, FumSPTA, was developed to achieve efficient soluble expression via a prokaryotic expression system. When combined with the coenzyme pyridoxal phosphate (PLP), it maintains high catalytic activity over a wide temperature and pH range and can convert HFB1 into the low-toxicity product 2-keto-HFB1.
Under optimal conditions, FumSPTA achieves a 70% degradation rate in 1 minute when 1 μg of enzyme reacts with 1 μg of HFB1, and complete degradation is achieved within 30 minutes. It has high degradation efficiency, wide applicability, and reduces the toxicity of HFB1.